Subscribe to MDT Magazine News

Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan

November 4, 2010 3:34 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, Nov. 4, 2010 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) today announced that the Company's Board of Directors (the "Board") has declared a one-time special dividend of US$1.00 per common share (the "Special Dividend") that shareholders of...


Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program

November 4, 2010 3:34 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Nov. 4, 2010 /- Stereotaxis, Inc. (Nasdaq: STXS ) announced today that it has been awarded $1.5 million in grants under the Qualifying Therapeutic Discovery Project Program that was enacted under the Patient Protection and Affordable Care Act of 2010.  The program targets...


Interventional Spine®, Inc. Announces Issuance of Key Patents for the PERPOS® PLS System

November 4, 2010 3:34 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., Nov. 4, 2010 /- Interventional Spine®, Inc. today announced that the United States Patent Office has issued U.S. Patent No. 7,824,429, entitled Method and Apparatus for Spinal Fixation.  This patent includes 43 claims that provide key patent protection for the...


Covidien Receives FDA 510(k) Clearance for Kendall SCD(TM) Compression Comfort Sleeve and Kendall SCD(TM) 700 Series Controller

November 4, 2010 3:32 am | by Covidien | Comments

New System Delivers Improved Comfort and Clinically Proven Compression Technology for Venous Thromboembolism MANSFIELD, Mass., Nov 04, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in intermittent pneumatic...


Biogen Idec to Close San Diego Site

November 3, 2010 11:31 pm | by San Diego Business Journal | Comments

Biogen Idec Inc., one of the world's largest makers of multiple sclerosis drugs, said Nov. 3 that it was restructuring its operations by closing its San Diego site along with two other facilities in Massachusetts.


20W GaN power amp provides 30% PAE

November 3, 2010 10:35 pm | by I-Micronews | Comments

TriQuint debuts the TGA2572 20W power amplifier designed for defence communications systems and fabricated using TriQuint's production-released GaN on SiC process.

REC facility already exceeds expectations by producing one millionth module ahead of plan before reaching full capacity.

November 3, 2010 10:34 pm | by I-Micronews | Comments

REC today officially opened one of the world's largest integrated wafer, cell and module manufacturing facilities in Tuas, Singapore. This milestone is the largest single investment ever made by REC, the largest clean tech investment ever made in Singapore at 2.5 billion Singapore...

Power Integrations announces strategic investment in SemiSouth Laboratories

November 3, 2010 10:34 pm | by I-Micronews | Comments

Clean-Tech innovators join forces in $30M partnership to accelerate development of energy-efficient power devices for solar, wind & hybrid/electric auto industries Investment to Help Spur Continued Growth of Clean-Tech Jobs in Mississippi


Teens of epileptic moms display poor school performance

November 3, 2010 9:37 pm | by EurekAlert | Comments

(Wiley-Blackwell) A large population-based study revealed that multiple antiepileptic drugs (AEDs) used by pregnant women to control seizures may cause poor school performance in their teenagers. The research team from Karolinska University Hospital and the University of Lund in...


A Target for Stroke Therapy Drugs

November 3, 2010 9:35 pm | by Massachusetts Institute of Technology | Comments

New understanding of post-stroke neurons could transform patient treatment and recovery. A drug that aids neuron repair has improved recovery in mice by as much as 50 percent.


Genetics spurs next generation of brain research

November 3, 2010 9:35 pm | by Baylor College of Medicine | Comments

The field of neurogenetics soared during the decade since scientists first released a draft sequence of the human genome, said leaders in the field from Baylor College of Medicine and Emory University School of Medicine in Atlanta in an overview published in the current issue of the...


Actavis Encourages Consumers to Return Fentanyl Transdermal System 25 mcg/h

November 3, 2010 9:34 pm | by Bio-Medicine.Org | Comments

MORRISTOWN, N.J., Nov. 3, 2010 /- Further to its previously announced voluntary recall of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches, Actavis is encouraging consumers to return any product in their possession from the October 21, 2010 recall. Consumers with Actavis 25...


Americans less healthy than English, but live as long or longer, study finds

November 3, 2010 9:33 pm | by EurekAlert | Comments

(RAND Corporation) Older Americans are less healthy than their English counterparts, but they live as long or even longer than their English peers, according to a new study.Researchers found that while Americans aged 55 to 64 have higher rates of chronic diseases than their peers in...


BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year

November 3, 2010 5:36 pm | by Bio-Medicine.Org | Comments

FRANKLIN LAKES, N.J., Nov. 3, 2010 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today reported quarterly revenues of $1.873 billion for the fourth fiscal quarter ended September 30, 2010, representing an increase of 1.0 percent from the...


Cardiogenesis Reports Third Quarter 2010 Results

November 3, 2010 5:35 pm | by Bio-Medicine.Org | Comments

IRVINE, Calif., Nov. 3, 2010 /- Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used in the treatment of diffuse coronary artery disease, today reported financial results for its third quarter and first nine months ended September 30, 2010. Revenue for...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.